FTRE Stock Analysis: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$18.39
0.20 (1.10%)
▲
5d:
+5.63%
30d:
-5.69%
90d:
+39.95%
BUY
HIGH Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FTRE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: FTRE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.14
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.20
13.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $18.39, which is considered fair relative to its 30-day fair value range of $17.70 to $19.36. The stock's valuation (Forward PE: 16.1) is in line with its historical norms (15.4). At these levels, the market is pricing in 1.7% annual earnings growth.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $16.84, while resistance sits at $19.59.
Market Sentiment: FTRE scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.55 (+11.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FTRE is in a strong uptrend. Immediate support is located at $16.84, while resistance sits at $19.59.
Market Sentiment: FTRE scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $20.55 (+11.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$17.70 -
$19.36
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (72/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($20.55)
- BULLISH: Expecting earnings turnaround to 1.7% growth with -4.5% revenue growth
- BULLISH: Bottoming setup score 72/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$17.70 -
$19.36
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$16.84
Resistance Level
$19.59
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.15
Wall Street Target
$20.55
(+11.7%)
Revenue Growth (YoY)
-4.5%
Earnings Growth (YoY)
-57.4%
Profit Margin
-3.2%
Valuation Premium vs History
+1.7% premium
PE vs Historical
16.2 vs 15.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.7%
(market-implied from PE analysis)
1-Year Target
$18.70
(+2%)
2-Year Target
$19.02
(+3%)
3-Year Target
$19.34
(+5%)
3-Yr Target (if PE normalizes)
(PE: 16→15)
PE COMPRESSION
$18.44
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 35.5%)
$56.81
(+209%)
Base:
(SPY PE: 16.2, Growth: 35.5%)
$45.72
(+149%)
Bear:
(PE: 13.7, Growth: 35.5%)
$38.86
(+111%)
Share & Embed Analysis
Last updated: August 24, 2026 6:16 AM ET
Data refreshes hourly during market hours. Next update: 7:16 AM
Data refreshes hourly during market hours. Next update: 7:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jill G Mcconnell
SELL
1804 shares
2026-03-16
Jill G Mcconnell
SELL
5061 shares
2026-03-10
Robert Parks
SELL
1927 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 40 SELL |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
